Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled... von Dodick, David W, Prof, Goadsby, Peter J, Prof, Spierings, Egilius L H, Prof, Scherer, Joel C, MD, Sweeney, Steven P, BSc, Grayzel, David S, MD

Volltext

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study von Bigal, Marcelo E, Dr, Edvinsson, Lars, Prof, Rapoport, Alan M, MD, Lipton, Richard B, Prof, Spierings, Egilius L H, MD, Diener, Hans-Christoph, Prof, Burstein, Rami, PhD, Loupe, Pippa S, PhD, Ma, Yuju, MS, Yang, Ronghua, PhD, Silberstein, Stephen D, Prof

Volltext

Celecoxib Oral Solution and the Benefits of Self-Microemulsifying Drug Delivery Systems (SMEDDS) Technology: A Narrative Review von Silberstein, Stephen, Spierings, Egilius L. H., Kunkel, Todd

Volltext

tDCS-Induced Analgesia and Electrical Fields in Pain-Related Neural Networks in Chronic Migraine von DaSilva, Alexandre F., Mendonca, Mariana E., Zaghi, Soroush, Lopes, Mariana, DosSantos, Marcos Fabio, Spierings, Egilius L., Bajwa, Zahid, Datta, Abhishek, Bikson, Marom, Fregni, Felipe

Volltext

A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee von Spierings, Egilius L.H., Fidelholtz, James, Wolfram, Gernot, Smith, Michael D., Brown, Mark T., West, Christine R.

Volltext

Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials von Smith, Timothy R., Spierings, Egilius L. H., Cady, Roger, Hirman, Joe, Schaeffler, Barbara, Shen, Vivienne, Sperling, Bjørn, Brevig, Thomas, Josiassen, Mette Krog, Brunner, Elizabeth, Honeywell, Loan, Mehta, Lahar

Volltext

Cardiovascular outcomes in adults with migraine treated with eptinezumab for migraine prevention: pooled data from four randomized, double-blind, placebo-controlled studies von Smith, Timothy R., Spierings, Egilius L. H., Cady, Roger, Hirman, Joe, Ettrup, Anders, Shen, Vivienne

Volltext

Improvements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inadequate respons... von Spierings, Egilius L. H., Ning, Xiaoping, Ramirez Campos, Verena, Cohen, Joshua M., Barash, Steve, Buse, Dawn C.

Volltext

Efficacy and safety of fremanezumab in patients with migraine and inadequate response to prior preventive treatment: subgroup analyses by country of a randomized, placebo-controlle... von Spierings, Egilius L. H., Kärppä, Mikko, Ning, Xiaoping, Cohen, Joshua M., Campos, Verena Ramirez, Yang, Ronghua, Reuter, Uwe

Volltext

Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine von Winner, Paul K., Spierings, Egilius L. H., Yeung, Paul P., Aycardi, Ernesto, Blankenbiller, Tricia, Grozinski‐Wolff, Melissa, Yang, Ronghua, Ma, Yuju

Volltext

Menstrual‐Cycle and Menstruation Disorders in Episodic vs Chronic Migraine: An Exploratory Study von Spierings, Egilius L.H., Padamsee, Aliya

Volltext

Sufficiency and Necessity in Migraine: How do we Figure Out if Triggers are Absolute or Partial and, if Partial, Additive or Potentiating? von Spierings, Egilius L. H., Donoghue, Stephen, Mian, Alec, Wöber, Christian

Volltext

Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials von Smith, Timothy R., Spierings, Egilius L. H., Cady, Roger, Hirman, Joe, Schaeffler, Barbara, Shen, Vivienne, Sperling, Bjørn, Brevig, Thomas, Josiassen, Mette Krog, Brunner, Elizabeth, Honeywell, Loan, Mehta, Lahar

Volltext

A Randomized, Double-Blind, Placebo-Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP-825) in the Treatment of Acute Migraine (The TARGET Study) von Cady, Roger K., McAllister, Peter J., Spierings, Egilius L.H., Messina, John, Carothers, Jennifer, Djupesland, Per G., Mahmoud, Ramy A.

Volltext

Efficacy and Safety of Lubiprostone in Patients with Opioid-Induced Constipation: Phase 3 Study Results and Pooled Analysis of the Effect of Concomitant Methadone Use on Clinical O... von Spierings, Egilius L H, Drossman, Douglas A, Cryer, Byron, Mazen Jamal, M, Losch-Beridon, Taryn, Mareya, Shadreck M, Wang, Martin

Volltext

A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of epis... von Munjal, Sagar, Brand-Schieber, Elimor, Allenby, Kent, Spierings, Egilius L.H., Cady, Roger K., Rapoport, Alan M.

Volltext

Hemicrania Continua Should NOT Be Classified as a Trigeminal Autonomic Cephalalgia von Spierings, Egilius L. H.

Volltext

Daily Triptan Use for Intractable Migraine von Spierings, Egilius L.H.

Volltext

Intranasal noninhaled carbon dioxide for the symptomatic treatment of seasonal allergic rhinitis von Casale, Thomas B., MD, Romero, Francisco A., MS, Spierings, Egilius L.H., MD, PhD (Pharmacol)

Volltext

Efficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain: results of a phase 3, enriched enrollment, randomize... von Gimbel, Joseph, Spierings, Egilius L.H., Katz, Nathaniel, Xiang, Qinfang, Tzanis, Evan, Finn, Andrew

Volltext